Characterization of monoclonal antibody 436 recognizing the ARG-PRO-ALA-PRO sequence of the polymorphic epithelial mucin (PEM) protein core in breast carcinoma cells

M. Nuti, V. Turchi, A. Rughetti, P. Viacava, A. M. Masci, M. Castagna, L. Frati

Research output: Contribution to journalArticle

Abstract

Epithelial mucins have obtained increasing clinical relevance since they were found in the serum of cancer patients and were shown to be elevated in metastatic disease. We report here the characterization of the monoclonal antibody (MAb) 436 which recognises the protein core of the polymorphic epithelial mucin (PEM) of the human breast. MAb 436 was generated by immunizing Balb/c mice with membrane-enriched fractions prepared from metastatic lesions in the axillary lymph nodes. The antigenic determinant recognized by the MAb 436 is expressed on the surface of breast cancer cells and was measured by ELISA on all of 50 cytosol preparations of primary breast tumors. Immunohistochemistry showed 98% of primary and 100% of metastatic breast cancer lesions to be positive with the 436 antigenic determinant expressed both in the cytoplasm and at the plasma membrane level of the tumor cells. Moreover, the antigen was expressed in a homogeneous fashion (80-100% of the total number of tumor cells) in more than 60% of the tumors. Reactivity with normal tissues was rare and scattered and restricted to glandular structures particularly at the luminal border level except for the distal and collecting tubules of adult and fetal kidney, where a cytoplasmic 436 antigen distribution was observed. Other cancers proved positive but the reactivity was always variable and heterogeneous. The antigen recognized by MAb 436 appears in Western Blotting as a Mr of more than 200,000 daltons protein resolved in two bands. Epitope mapping experiments using overlapping octapeptides in the repeat unit of the PEM identified in the RPAP (Arg-Pro-Ala-Pro) sequence the binding site of the 436 antigen. With the selective reactivity shown and the homogeneous expression of the corresponding epitope in breast cancer cells of primary and metastic lesions, the MAb 436 represents a good reagent with potential application in the diagnosis and therapy of breast cancer.

Original languageEnglish
Pages (from-to)71-79
Number of pages9
JournalInternational Journal of Biological Markers
Volume7
Issue number2
Publication statusPublished - 1992

    Fingerprint

ASJC Scopus subject areas

  • Biochemistry
  • Immunology

Cite this